RxDoctor Payments Data

Sheena Locketti, APRN

Psychiatric/Mental Health · Youngstown, OHNPI 1265198402

Payments from drug & device makers

$2,276in general payments, 2019–2025

Across 179 payments — averaging $12.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$687
  • Lundbeck LLC$476
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$232
  • Teva Pharmaceuticals USA, Inc.$212
  • Johnson & Johnson$190
  • Otsuka America Pharmaceutical, Inc.$178
  • plus $302 from 4 others

What the payments were for

  • Food & beverage$2,22998%
  • Education$472%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,276 in reported general payments places this provider in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.

See all psychiatric/mental health providers in Ohio

Medicare billing

Part B allowed, 2024
$5,706
Medicare patients
18
Services billed
66

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Invega SustennaPaliperidone Palmitate104$352,975
Abilify AsimtufiiAripiprazole20$117,940
Abilify MaintenaAripiprazole35$102,741
VraylarCariprazine Hcl63$89,126
LybalviOlanzapine/Samidorphan Malate17$50,952
AristadaAripiprazole Lauroxil20$47,176
Risperidone ErRisperidone Microspheres21$23,354
Clozapine215$11,539
Paliperidone ErPaliperidone88$9,406
TrintellixVortioxetine Hydrobromide11$5,084
Divalproex Sodium286$4,618
Aripiprazole65$3,664
Haloperidol Decanoate62$3,662
Benztropine Mesylate248$3,236
Oxcarbazepine105$2,848

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonInvega Sustenna$190$352,975104 claims
Otsuka America Pharmaceutical, Inc.Abilify Asimtufii, Abilify Maintena$178$220,68055 claims
Alkermes, Inc.Lybalvi, Aristada$66$98,12737 claims
AbbVieVraylar$687$89,12663 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,808 psychiatric/mental health providers in Ohio.

Other psychiatric/mental health in Youngstown

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →